Drug intelligence / Profile preview

Hecolin + hepatitis B vaccine

Development stage: Unknown
Lead developer: Xiamen Innovax Biotech
Modality: Vaccines & Immunotherapeutics
Administration: Intramuscular

Overview

Hecolin + hepatitis B vaccine is a co-administered vaccine regimen developed by Xiamen Innovax Biotech for the simultaneous prevention of hepatitis E and hepatitis B infections. Hecolin (HEV 239) is a recombinant virus-like particle (VLP) vaccine expressed in *Escherichia coli*, representing the structural protein of the hepatitis E virus (genotype 1). The hepatitis B component is a recombinant vaccine containing the hepatitis B surface antigen (HBsAg). This combination is primarily evaluated for safety and immunogenicity in healthy adults to simplify immunization schedules in endemic regions where both viruses are prevalent.

Brand names: Hecolin
Other names: Recombinant Hepatitis E Vaccine (Escherichia Coli)Recombinant Hepatitis B Vaccinehepatitis B vaccine-Xiamen Innovax Biotech Co., Ltd-hepatitis E

Targets

HBsAg (Hepatitis B surface antigen)HEV ORF2 (Hepatitis E virus capsid protein)

Beyond the preview

Go deeper on Hecolin + hepatitis B vaccine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hecolin + hepatitis B vaccine.

Explore the full profile